Dose-response relationship seen with risk heightened with longer duration exposure
ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
Larger reductions seen in heart failure-related symptoms and physical limitations for patients with HFpEF, type 2 diabetes
ACC: Ventura Shunt Does Not Improve Primary End Point in Heart Failure
Improvements noted across all outcomes assessed in patients with heart failure with reduced ejection fraction
Etidronate Beneficial for Arterial Calcification Due to CD73 Deficiency
Etidronate seems to slow progression of further vascular calcification
Salt Substitution May Reduce All-Cause, Cardiovascular Mortality
Slight reduction seen in major cardiovascular events; very low certainty of serious adverse events reported
ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
Lower risk for clinically relevant bleeding seen in acute coronary syndrome, with no increase in risk for MACCE
ACC: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI
Lower risks for first heart failure hospitalization, total heart failure hospitalization seen with empagliflozin
ACC: AI-Based Video Biomarker Detects Aortic Stenosis Progression
Higher baseline Digital AS Severity index associated with faster progression in aortic valve velocity
Electronic Cigarettes May Help Regular Cigarette Smokers Quit
Vaping tied to greater cigarette quitting in more recent years
EHR-Based Algorithm Does Not Cut Hospitalization in Kidney Dysfunction Triad
No reduction seen in hospitalization at one year with use of EHR-based algorithm and practice facilitators in primary care